Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
The research investigated the role of Equine herpesvirus type 2 (EHV-2) as a contributing factor to Rhodococcus equi pneumonia in foals and found that immunizing against EHV-2 could effectively prevent the disease complex.
Study Overview
The study delved into the respiratory disease complex in foals that was believed to be influenced by the presence of Equine herpesvirus type 2 (EHV-2). The research was centred around the claim that EHV-2 infection in foals made them more susceptible to a secondary bacterial invasion by Rhodococcus equi (R. equi), leading to the development of pneumonia.
Evaluating the Role of EHV-2
- The researchers aimed to determine the role of EHV-2 by observing the occurrence of the respiratory disease complex in foals immunized against EHV-2 and comparing it to a control group of foals that were not immunized.
- For the immunization, a subunit vaccine was used that selectively presents the envelope glycoproteins of EHV-2 in a multimeric form known as immunostimulating complexes (ISCOMs).
Immunization Findings
- The vaccine trials showed that the ISCOM subunit formulation was capable of overcoming the interference from maternal antibodies in foals.
- A single dose of the ISCOMs vaccine provided some degree of protection to the foals. However, two injections offered full protection against the respiratory disease complex to most of the treated animals.
- Effectively, the symptom manifestation of R. equi pneumonia was prevented with the ISCOMs immunization, buttressing the idea that EHV-2 was a key contributing factor for the R. equi invasion of the respiratory tract in foals.
Conclusion
This study projects EHV-2 as a significant factor for susceptibility to R. equi pneumonia in young foals. The research findings also accentuate the potential of the EHV-2 ISCOM formulation as a highly specific and effective preventive measure against the disease.
Cite This Article
Publication
Researcher Affiliations
- Department of Virology, National Veterinary Institute, Uppsala, Sweden.
MeSH Terms
- Actinomycetales Infections / etiology
- Actinomycetales Infections / microbiology
- Actinomycetales Infections / prevention & control
- Actinomycetales Infections / veterinary
- Animals
- Herpesviridae / immunology
- Herpesviridae Infections / complications
- Herpesviridae Infections / microbiology
- Herpesviridae Infections / prevention & control
- Herpesviridae Infections / veterinary
- Horse Diseases / immunology
- Horse Diseases / microbiology
- Horse Diseases / prevention & control
- Horses
- ISCOMs / administration & dosage
- ISCOMs / chemistry
- Mice
- Mice, Inbred BALB C
- Pilot Projects
- Pneumonia, Bacterial / etiology
- Pneumonia, Bacterial / microbiology
- Pneumonia, Bacterial / prevention & control
- Pneumonia, Bacterial / veterinary
- Rhodococcus equi
- Viral Vaccines / administration & dosage
Citations
This article has been cited 23 times.- Asin J, Carvallo F, Gonzales-Viera OA, Macías-Rioseco M, Streitenberger N, Abdelrazek S, Crossley B, Pesavento PA, Uzal FA. Interstitial pneumonias of undetermined etiology in foals in California, 1990-2020. J Vet Diagn Invest 2026 Jan 29;:10406387251410524.
- Matos MC, Abrantes J, Lopes AM. Widespread presence of novel gammaherpesviruses in lagomorph species (Oryctolagus cuniculus, Lepus spp. and Ochotona alpina). Virol J 2025 Dec 24;22(1):398.
- James K, Chappell DE, Craig B, Pariseau C, Wright C, van Harreveld P, Barnum S, Pusterla N. Investigation of Selected Prevalence Factors Associated with EHV-2 and/or EHV-5 Infection in Horses with Acute Onset of Fever and Respiratory Signs. Viruses 2025 Apr 25;17(5).
- Rakowska A, Marciniak-Karcz A, Bereznowski A, Cywińska A, Żychska M, Witkowski L. Less Typical Courses of Rhodococcus equi Infections in Foals. Vet Sci 2022 Oct 31;9(11).
- Badr C, Souiai O, Arbi M, El Behi I, Essaied MS, Khosrof I, Benkahla A, Chabchoub A, Ghram A. Epidemiological and Phylogeographic Study of Equid Herpesviruses in Tunisia. Pathogens 2022 Sep 5;11(9).
- Wondimagegnehu K, Leta S, Amenu K, Negussie H. Molecular detection and assessment of the epidemiological risk factors associated with equine herpesvirus 2 and 5 in working equids in central Ethiopia. Vet Med Sci 2022 Nov;8(6):2396-2403.
- Onasanya AE, El-Hage C, Diaz-Méndez A, Vaz PK, Legione AR, Browning GF, Devlin JM, Hartley CA. Whole genome sequence analysis of equid gammaherpesvirus -2 field isolates reveals high levels of genomic diversity and recombination. BMC Genomics 2022 Aug 30;23(1):622.
- Stasiak K, Dunowska M, Rola J. Kinetics of the Equid Herpesvirus 2 and 5 Infections among Mares and Foals from Three Polish National Studs. Viruses 2022 Mar 29;14(4).
- Temesgen T, Getachew Y, Negussie H. Molecular Identification of Equine Herpesvirus 1, 2, and 5 in Equids with Signs of Respiratory Disease in Central Ethiopia. Vet Med (Auckl) 2021;12:337-345.
- El-Hage C, Mekuria Z, Dynon K, Hartley C, McBride K, Gilkerson J. Association of Equine Herpesvirus 5 with Mild Respiratory Disease in a Survey of EHV1, -2, -4 and -5 in 407 Australian Horses. Animals (Basel) 2021 Nov 30;11(12).
- Tsai MS, Newman C, Macdonald DW, Buesching CD. Stress-Related Herpesvirus Reactivation in Badgers Can Result in Clostridium Proliferation. Ecohealth 2021 Dec;18(4):440-450.
- Tsai MS, François S, Newman C, Macdonald DW, Buesching CD. Patterns of Genital Tract Mustelid Gammaherpesvirus 1 (Musghv-1) Reactivation Are Linked to Stressors in European Badgers (Meles Meles). Biomolecules 2021 May 11;11(5).
- Thorsteinsdóttir L, Jónsdóttir S, Stefánsdóttir SB, Andrésdóttir V, Wagner B, Marti E, Torsteinsdóttir S, Svansson V. The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response. PLoS One 2019;14(6):e0218576.
- Dall Agnol AM, Beuttemmuller EA, Pilz D, Leme RA, Saporiti V, Headley SA, Alfieri AF, Alfieri AA. Detection of Equid gammaherpesvirus 2 and 5 DNA in the upper respiratory tract of asymptomatic horses from Southern Brazil. Braz J Microbiol 2019 Jul;50(3):875-878.
- Azab W, Bedair S, Abdelgawad A, Eschke K, Farag GK, Abdel-Raheim A, Greenwood AD, Osterrieder N, Ali AAH. Detection of equid herpesviruses among different Arabian horse populations in Egypt. Vet Med Sci 2019 Aug;5(3):361-371.
- Muscat KE, Padalino B, Hartley CA, Ficorilli N, Celi P, Knight P, Raidal S, Gilkerson JR, Muscatello G. Equine Transport and Changes in Equid Herpesvirus' Status. Front Vet Sci 2018;5:224.
- Marenzoni ML, Stefanetti V, Danzetta ML, Timoney PJ. Gammaherpesvirus infections in equids: a review. Vet Med (Auckl) 2015;6:91-101.
- Stasiak K, Dunowska M, Rola J. Prevalence and sequence analysis of equid herpesviruses from the respiratory tract of Polish horses. Virol J 2018 Jul 11;15(1):106.
- Marenzoni ML, Bietta A, Lepri E, Casagrande Proietti P, Cordioli P, Canelli E, Stefanetti V, Coletti M, Timoney PJ, Passamonti F. Role of equine herpesviruses as co-infecting agents in cases of abortion, placental disease and neonatal foal mortality. Vet Res Commun 2013 Dec;37(4):311-7.
- Venn-Watson S, Benham C, Gulland FM, Smith CR, St Leger J, Yochem P, Nollens H, Blas-Machado U, Saliki J, Colegrove K, Wellehan JF Jr, Rivera R. Clinical relevance of novel Otarine herpesvirus-3 in California sea lions (Zalophus californianus): lymphoma, esophageal ulcers, and strandings. Vet Res 2012 Dec 12;43(1):85.
- Shewen PE, Carrasco-Medina L, McBey BA, Hodgins DC. Challenges in mucosal vaccination of cattle. Vet Immunol Immunopathol 2009 Mar 15;128(1-3):192-8.
- Giguère S, Hernandez J, Gaskin J, Prescott JF, Takai S, Miller C. Performance of five serological assays for diagnosis of Rhodococcus equi pneumonia in foals. Clin Diagn Lab Immunol 2003 Mar;10(2):241-5.
- Hu KF, Elvander M, Merza M, Akerblom L, Brandenburg A, Morein B. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses. Clin Exp Immunol 1998 Aug;113(2):235-43.